Summary
Eight patients treated with a total of 220–550 million U penicillin-G developed neutropenia. These cases have been compared with eight patients receiving a similar dose of penicillin-G with no adverse reactions and with eight untreated subjects. All penicillin-treated patients showed raised levels of antipenicillin IgG antibodies and lymphocyte culture stimulation indices. These values were highest in the neutropenia group. Both of the two tests significantly descriminated the three groups. Antineutrophil antibodies could be detected in four of seven neutropenic patients with a staphylococcal-slide-assay while indirect immunofluorescence and microcytotoxicity tests failed to reveal these antibodies. The literature dealing with neutropenias induced by penicillin-G and its congeners is reviewed. We conclude that (1) penicillin-G in doses exceeding a total of 200 million U frequently induces neutropenia, (2) an immune-mediated pathogenesis is highly probable, (3) neutropenia after penicillins is different from two hither-to accepted types of this side effect, (4) sufficiently high amounts of penicillin-G intravenously always induce sensitization against this drug.
Zusammenfassung
Acht Patienten entwickelten nach total 220–550 Millionen E Penicillin-G i.v. eine Neutropenie. Wir verglichen immunologische Daten dieser Fälle mit denjenigen von acht Patienten, die mit vergleichbaren Penicillin-G-Dosen ohne ersichtliche Nebenwirkungen behandelt wurden, sowie mit denjenigen von acht unbehandelten Gesunden. Alle mit Penicillin Behandelten zeigten im Vergleich zu den Unbehandelten erhöhte Spiegel von anti-Penicillin IgG und einen stark positiven Lymphozyten-Stimulationstest mit Penicillin. Beide Untersuchungen ergaben die höchsten Werte innerhalb der Neutropeniegruppe und unterschieden alle drei Gruppen signifikant voneinander. Bei vier von sieben Neutropenikern konnten mit einem Objektträgertest unter Verwendung von Protein A enthaltenden Staphylokokken, antineutrophile Antikörper nachgewiesen werden. Mit indirekter Immunfluoreszenz und Mikrozytotoxizitätstest gelang dagegen in keinem Fall ein Antikörpernachweis. Die Literatur über Neutropenie nach Penicillin und seinen Derivaten wurde durchgesehen. Schlußfolgerungen: (1) Über 200 Mio E Penicillin-G i.v. induziert häufig eine Neutropenie, (2) ein immunvermittelter Mechanismus ist sehr wahrscheinlich, (3) die Neutropenie nach Penicillinen ist nicht identisch mit einem der zwei bisher akzeptierten Typen der medikamentös induzierten Immunneutropenie (Amidopyrin-Typ resp. Procainamid-Typ), (4) genügend hohe Dosen von Penicillin-G erzeugen immer einen positiven Lymphozyten-Stimulationstest und einen Anstieg von Penicillin-spezifischen IgG.
Similar content being viewed by others
References
Graf M, Tarlov A (1968) Agranulocytosis with monohistiocytosis associated with ampicillin therapy. Ann Int Med 69:91–95
Henon P, Kazatchkine HP, Gerota M (1976) Aplasie medullaire après traitement per ampicilline. Nouv Presse Med 5:2331
Kancir LM, Tuazon CU, Cardella TA, Sheagren JN (1978) Adverse reactions to methicillin and nafcillin during treatment of serious staphylococcus aureus infections. Arch Int Med 138:909–911
Stille W (1969) Reversible allergische Agranulozytose unter der Therapie mit Ampicillin. Med Welt 36:1981–1984
Hofman G, Saule H (1978) Neutropenie als Nebenwirkung von Azlocillin bei einem Kind. Klin Pädiatr 191:418–420
Schacht P, Tettenborn D, Hullmann R, Bruck H (1979) Ergebnisse der klinischen Prüfung von Azlocillin. Arzneim-Forsch/Drug Res 29:1981–1985
Allo M, Silva J (1977) Antibiotic agranulocytosis: Association with cephalotin and carbenicillin. South Med J 70:1017–1019
Reyes MP, Palutke M, Lerner AM (1973) Granulocytopenia associated with carbenicillin. Am J Med 54:413–418
Krafft T, Pugin P, Miescher PA (1978) Agranulocytose et cloxacilline intraveineuse. Schweiz Med Wochenschr 108:1821–1823
Westerman EL, Bradshaw MW, Williams TW Jr (1978) Agranulocytosis during therapy with orally administered cloxacillin. Am J Clin Pathol 69:559–560
Weitzman SA, Stossel TP (1978) Drug-induced immunological neutropenia. Lancet 1:1068–1072
Hogan LB, Holloway WJ, Scott EG (1968) Clinical experience with hetacillin. Curr Ther Res 10:363–372
Romig DA, Liu C, Voth DW (1975) Neutropenia. Therapy with penicillin and its congeners. J Kans Med Soc 76:8–10
Bullock WE Jr (1961) Evaluation of 2,6-dimethoxyphenylpenicillin therapy in staphylococcal sepsis. Antimicrob Agents Chemother 770–778
Caldwell JR, Cluff LE (1974) Adverse reaction to antimicrobial agents. JAMA 230:77–80
Levitt BH, Gottlieb AJ, Rosenberg IR, Klein JJ (1964) Bone marrow depression due to methicillin, a semisynthetic penicillin. Clin Pharmacol Ther 5:301–306
McElfresh MD, Huang NN (1962) Bone marrow depression resulting from the administration of methicillin. N Engl J Med 266:246–247
Simon HJ, Rantz LA (1962) The newer penicillins: II. Clinical experience with methicillin and oxacillin. Ann Intern Med 57:344–362
Yow MD, Taber LH, Barret FF, Mintz A, Blaukinship GR, Clark GE, Clark DJ (1976) A ten-year assessment of methicillin-associated side effects. Pediatrics 58:329–334
Couchonal GJ, Hinthorn DR, Hodges GR, Liu C (1978) Nafcillin-associated granulocytopenia. South Med J 71:1356–1358
Greene GR, Cohen E (1978) Nafcillin-induced neutropenia in children. Pediatrics 61:94–97
Markowitz SM, Rothkopf M, Holden FD, Stith DM, Duma RJ (1975) Nafcillin-induced agranulocytosis. JAMA 232:1150–1152
Sandberg M, Tuazon CU, Sheagren JN (1975) Neutropenia probably resulting from nafcillin. JAMA 232:1152–1154
Wilson C, Greenhood G, Remington JS, Vosti KL (1979) Neutropenia after consecutive treatment courses with nafcillin and piperacillin. Lancet 1:1150
Wolf DJ, Resnick GD (1978) Nafcillin-induced neutropenia. NY State J Med 78:256–259
Zakhireh B, Root RK (1978) Unusually high occurrence of drug reactions with nafcillin. Yale J Biol Med 51:449–455
Ahern MJ, Hicks JE, Andriole VT (1976) Neutropenia during high dose intravenous oxacillin therapy. Yale J Biol Med 49:351–360
Arbeter AM, Tolpin MD, Piercy SA, Yachetti SD, Danish MS, Warren WS, Plotkin SA (1978) Nafcillin-oxacillin comparative clinical trial (abstr.) Pediat Res 12:489
Brook I (1977) Leukopenia and granulocytopenia after oxacillin therapy. South Med J 70:565–566
Chu JY, O'Connor DM, Schmidt RR (1977) The mechanism of oxacillin-induced neutropenia. J Pediatr 90:668–669
Freedman MA (1965) Oxacillin-apparent hematologic and hepatic toxicity. Rocky Mt Med J 62:34–36
Fallon JA, Tall AR, Janis MG, Brauer MJ (1978) Oxacillin-induced granulocytopenia. Acta Haematol 59:163–170
Homayouni H, Gross PA, Setia U, Lynch TJ (1979) Leukopenia due to penicillin and cephalosporin homologues. Arch Intern Med 139:827–828
Kahn JB (1978) Oxacillin-induced agranulocytosis. JAMA 240:2632
Leventhal MM, Silken AB (1976) Oxacillin-induced neutropenia in children. J Pediatr 89:769–771
Ortbals DW, Marr JJ (1977) Profound neutropenia caused by oxacillin. South Med J 70:1245–1246
Passoff TL, Sherry HS (1978) Oxacillin induced neutropenia. Clin Orthop 135:69–70
Bouza E, Buzón L, Martinez-Beltran J, Rodriquez M, Moneo I, Burgaleta C (1979) Complications of the treatment of bacterial infections with piperacillin. In: Nelson JD, Grassi C (eds) Proceedings of the 11th International Congress of Chemotherapy and 19th Interscience Conference of Antimicrobielle Agents Chemotherapy, Boston, pp 300–303
Colvin B, Rogers M, Layton C (1974) Benzylpenicillin-induced leukopenia. Br Heart J 36:216–219
Forshaw J (1968) Penicillin-induced granulocytopenia. Br Med J 3:184
Mock D, Abbott D, Choong A (1979) Un cas de neutropénie secondaire à la pénicilline. J Canad Dent Ass 45:334–336
Hasegawa T, Graw RG Jr, Terasaki PI (1973) A microgranulocyte cytotoxicity test. Transplantation 15:492–498
Verheugt FWA, Borne AEG Kr vd, Décary F, Engelfriet CP (1977) Detection of granulocyte alloantibodies by an indirect immunofluorescence test. Br J Haematol 36:533–544
Harmon DC, Weitzman SA, Stossel TP (1980) A staphylococcal slide test for detection of antineutrophil antibodies. Blood 56:64–69
Schellekens PTA, Eijsvogel VP (1968) Lymphocyte transformation in vitro. Clin Exp Immunol 3:571–584
Petz LD, Fudenberg HH (1966) Coombs-positive hemolytic anemia caused by penicillin administration. N Engl J Med 274:171–178
Rossiter MA, Gray IR, Shinton NK (1968) Penicillin-induced hemolytic anaemia. Br Med J 3:616–617
White JM, Brown DL, Hepner GW, Worlledge SM (1968) Penicillin-induced hemolytic anaemia. Br Med J 3:26–29
Paradisi F, Cioffi R, Ceccarelli G (1977) Granulocitopenia e piastrinopenia probabilmente dovute alla benzilpenicillina ed alla cefalotina. Giornale di Mallattie Infettive e Parassiterie 29:251–256
Joorabchi B, Kohout E (1973) Apparent penicillin-induced arrest of mature bone marrow elements. Br Med J 2:26–27
Pisciotta V (1978) Drug-induced agranulocytosis. Drugs 15:132–143
Moeschlin S, Wagner K (1952) Agranulocytosis due to the occurrence of leucocyte-agglutinins. Acta Haematol 8:29–41
Konttinen YP, Tuominen L (1971) Reversible procainamide-induced agranulocytosis twice in one patient. Lancet 2:925
Worlledge SM (1973) Immune drug-induced hemolytic anemias. Semin Haematol 10:327–344
Neftel KA, Wälti M, Spengler H, Rolli H, Schneider CH, de Weck AL (in prep)
Schneider CH (1970) Immunochemistry of penicillin. In: Stewart GT, McGovern JP (eds) Penicillin allergy. Springfield, Thomas, pp 23–58
Weck AL De, Schneider CH, Gutersohn J (1968) The role of penicilloylated protein impurities, penicillin polymers and dimers in penicillin allergy. Int Arch Allergy, 33:535–567
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Neftel, K.A., Wälti, M., Spengler, H. et al. Neutropenia after penicillins: Toxic or immune-mediated?. Klin Wochenschr 59, 877–888 (1981). https://doi.org/10.1007/BF01721921
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01721921